Biodesix, Inc. SG&A Expenses

SG&A Expenses of BDSX for past 10 years: annual, quarterly and twelve month trailing (TTM) including SG&A Expenses growth rates and interactive chart. Selling, general and administrative expense (SG&A) is reported on the income statement as the sum of all direct and indirect selling expenses and all general and administrative expenses (G&A) of a company. SG&A, also known as SGA, includes all the costs not directly tied to making a product or performing a service. That is, SG&A includes the costs to sell and deliver products and services and the costs to manage the company. It includes administrative

Highlights and Quick Summary

  • SG&A Expenses for the quarter ending September 30, 2022 was $15.1 Million (a -0.79% decrease compared to previous quarter)
  • Year-over-year quarterly SG&A Expenses increased by 11.48%
  • Annual SG&A Expenses for 2021 was $50.5 Million (a 44.93% increase from previous year)
  • Annual SG&A Expenses for 2020 was $34.9 Million (a 13.77% increase from previous year)
  • Annual SG&A Expenses for 2019 was $30.6 Million (a 18.29% increase from previous year)
  • Twelve month SG&A Expenses ending September 30, 2022 was $58.4 Million (a 2.65% increase compared to previous quarter)
  • Twelve month trailing SG&A Expenses increased by 15.59% year-over-year
Trailing SG&A Expenses for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$58.4 Million $56.9 Million $53.1 Million $50.5 Million
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical SG&A Expenses of Biodesix, Inc.

Most recent SG&A Expensesof BDSX including historical data for past 10 years.

Interactive Chart of SG&A Expenses of Biodesix, Inc.

Biodesix, Inc. SG&A Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $15.11 $15.24 $14.49
2021 $13.56 $13.61 $11.43 $11.93 $50.52
2020 $12.06 $7.88 $6.83 $8.08 $34.86
2019 $6.56 $8.21 $30.64
2018 $25.9

Business Profile of Biodesix, Inc.

Sector: Healthcare
Industry: Diagnostics & Research